Helomics Predictive Oncology Announces $4.1M Direct Offering On Thursday, Predictive Oncology closed another direct offering initiated earlier in the week, raising $2.2 million. Predictive Oncology Prices $2.2M Direct Offering The company has reached agreements with investors for a direct offering of 2.2 million shares at $1 per share, for gross proceeds of about $2.2 million. Predictive Oncology Prices $3.2M Public Offering The company operates three subsidiaries including Helomics, which provides tumor-analysis services for treatment personalization and new drug development. Helomics Inks Separate Pacts With UPMC, Interpace Dx for AI-Driven Oncology Decision Making The groups will use Helomics' artificial intelligence-based platform to develop tools to provide predictive therapeutic recommendations for ovarian and thyroid cancers. Helomics, ChemImage Partner on Prostate Cancer Monitoring Tech Development Through the deal, Helomics aims to build a predictive model of prostate cancer drug response based on a combination of genomic and spectroscopy data. Jun 14, 2019 People in the News: Thomas Schinecker, Amelia Warner, Bartu Ahiska, More Mar 21, 2019 Viome, Helomics Form Microbiome Analysis Partnership Aug 17, 2018 New Products Posted to GenomeWeb: Helomics, Empirical Bioscience, IncellDx, More Jun 29, 2018 Precision Therapeutics, Helomics Ink Merger Agreement Apr 23, 2018 Precision Therapeutics to Acquire Remaining Helomics Shares Dec 20, 2017 Helomics Inks Service Agreement for Ariel Precision Medicine Pancreatic Disease Assay Dec 20, 2017 Skyline Medical to Acquire Up to 25 Percent of Helomics Nov 1, 2017 Skyline Medical, Helomics Collaborate to Develop Personalized Cancer Dx Sep 19, 2017 Indivumed, Helomics Form Cancer Research Services Partnership Jan 12, 2017 Helomics, MDNA Partner on Diagnostics Dec 21, 2016 Helomics Completes Restructuring to Clinical CRO Nov 29, 2016 Med BioGene, Helomics Revise Licensing Agreement Feb 12, 2016 Helomics Continues Research Market Shift With Two New Components for Live Cell Platform Premium Mar 26, 2015 Helomics Joins UK Consortium to Support Cancer Dx, Therapeutics Development Mar 11, 2015 Helomics, Prime Health Services Ink Tumor Profiling Deal Jan 27, 2015 Helomics Reinvents Itself, Targets Personalized Healthcare Space with Omics Assets Premium Nov 12, 2014 Precision Therapeutics Renames Itself Helomics, Nabs $60M Investment Aug 15, 2014 Med BioGene Poised to take Precision Therapeutics to Arbitration over Milestone Payment Mar 24, 2014 Precision Therapeutics CLIA-Certified to Offer Med BioGene's GeneFx Lung Assay Jan 28, 2014 Precision Therapeutics, Partners Validate Almac's ColDx Colorectal Cancer Test ahead of US Launch Premium Load More Breaking News Children With Autism May Have Underdeveloped Gut Microbiomes, Metagenomic Analysis Finds Kiromic BioPharma Acquires InSilico Solutions Bio-Rad Laboratories, 10x Genomics Settle IP Lawsuits, Sign Global Cross-Licensing Agreement Scope Fluidics Obtains CE Mark for PCR-Based SARS-CoV-2 Panel MeMed COVID-19 Prognostic Test Receives CE Mark ERS Genomics Licenses CRISPR IP to Japan SLC The Scan Dropped Charges The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal. More Kids The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children. PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more. Purnell Choppin Dies Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.